Dataset Information

Clinically Important Differences for Mobility Measures Derived from the Testosterone Trials.

ABSTRACT:

Background/objectives

Accurate estimates of clinically important difference (CID) are required for interpreting the clinical importance of treatments to improve physical function, but CID estimates vary in different disease populations. We determined the CID for two common measures of walking ability in mobility-limited older men.

Design

Longitudinal, multisite placebo-controlled trial.

Setting/participants

Men enrolled in the Testosterone Trials who had self-reported mobility limitation and gait speed less than 1.2 m/second (n = 429). Testosterone- and placebo-allocated participants were combined for this study.